MINNEAPOLIS, March 22, 2016 -- Charles H. Johnson & Associates announces that it has begun an investigation into the merger/inversion of LivaNova plc (formerly Cyberonics, Inc, a Delaware corporation, “Cyberonics”) and Sorin, S.p.A (“Sorin”), pursuant to which Cyberonics moved its corporate domicile from Delaware to the United Kingdom. On September 24, 2015, Cyberonics announced that its shareholders had approved the merger.
The acquisition was structured as a “tax inversion” to substantially lower Cyberonics’ tax rate on its foreign earnings by replacing the U.S. tax rates to which its foreign earnings were subject with the much lower United Kingdom tax rate.
Because it was structured as an inversion, the merger was treated as taxable to Cyberonics shareholders as it was considered a sale by Cyberonics shareholders of their shares, rather than a tax-free exchange as is typically the case in such transactions. Many Cyberonics shareholders who had held their stock for more than a year were forced to pay federal taxes at rates of 15% to 30% on their gains, in addition to state taxes.
The investigation is looking into whether the Cyberonics Board of Directors adequately represented the interests of Cyberonics’ shareholders in connection with the Sorin acquisition and, if not, whether such failure constituted a breach of fiduciary duty by the Cyberonics Board of Directors and whether Cyberonics or others aided and abetted such breach or violated other laws.
If you held Cyberonics stock and were subject to capital gains or other taxes due to the Sorin acquisition, or have any questions concerning this notice or your rights with respect to this matter, please contact:
Jonathan R. Mencel, Esq. ([email protected])
Law Offices of Charles H. Johnson, P.A.
2599 Mississippi Street
New Brighton, MN 55112
(651) 633-5685


Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Samsung Electronics Shares Jump on HBM4 Mass Production Report
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



